Welcome to our dedicated page for Oddity Tech news (Ticker: ODD), a resource for investors and traders seeking the latest updates and insights on Oddity Tech stock.
ODDITY Tech Ltd. develops and scales digital-first beauty, wellness and telehealth brands through an AI-driven online platform. Company news commonly covers financial results, outlook updates, repeat-customer sales trends, gross margin and adjusted EBITDA, along with product development across IL MAKIAGE, SpoiledChild, METHODIQ and ODDITY Labs.
Recurring developments also include launches of new consumer and medical-care offerings, use of data science and computer vision in online diagnosis and product matching, dermatology-focused treatments through METHODIQ, and capital actions such as Class A ordinary share repurchase authorizations.
ODDITY Tech (NASDAQ: ODD) reported Q1 2026 net revenue of $197.9 million, down 26% year-over-year, with a net loss of $21.4 million and Adjusted EBITDA of $(7.0) million. Gross margin fell to 69.7% from 74.9%.
According to ODDITY, higher customer acquisition costs (CPA) tied to its largest advertising partner sharply reduced first orders and media efficiency, though IL MAKIAGE CPA in May declined an estimated 28% sequentially from April. The company guided Q2 2026 net revenue down 25–30% and expects Adjusted EBITDA of $8–$10 million and positive Adjusted EBITDA for full-year 2026.
Liquidity included $667.4 million in cash, cash equivalents and investments plus $350 million in undrawn credit facilities. The board authorized a $200 million share repurchase; in Q1 ODDITY bought back about 6.1 million Class A shares for $82.3 million, reducing Class A shares outstanding by roughly 10.6%, leaving $167.3 million available.
ODDITY (NASDAQ: ODD) will release its first quarter 2026 financial results before the market open on Tuesday, June 2, 2026, followed by an earnings conference call at 8:30 a.m. Eastern Time.
Dial-in numbers, webcast access, replay details, and a seven-day archive are provided for investors.
ODDITY Tech (NASDAQ: ODD) announced a $200 million share buyback plan approved by its Board on March 12, 2026. The Buyback Plan replaces a prior $150 million program and will expire on March 31, 2029 or when funds are fully deployed.
Oddity previously repurchased approximately $97 million under the prior authorization, including about $50 million year-to-date. Repurchases may occur in the open market, via Rule 10b5-1 plans, or in privately negotiated transactions, and the plan does not obligate the company to repurchase any specific number of shares.
ODDITY Tech (NASDAQ: ODD) reported record 2025 results with $810M full year net revenue, up 25% YoY, and fourth quarter net revenue of $153M, up 24% YoY. Full year adjusted EBITDA was $163M and cash, equivalents and investments totaled $776M.
Management flagged an advertising partner dislocation that raised new user acquisition costs and expects Q1 2026 revenue to decline ~30% YoY, while retaining a $103M remaining buyback authorization.
ODDITY (NASDAQ: ODD) will release its fourth quarter and full year 2025 financial results before market open on February 25, 2026, followed by a conference call at 8:30 a.m. ET.
According to the company, a live webcast and dial-in access are available, with a replay archived on the investor website for seven days. Replay access code: 13758683.
ODDITY (NASDAQ: ODD) reported record third quarter results for the period ended September 30, 2025, with Q3 net revenue $148M (+24% YoY) and nine-month net revenue $657M (+26% YoY). Q3 gross profit was $106M and gross margin improved to 71.6% (+170 bps). Q3 adjusted EBITDA was $29M and nine-month adjusted EBITDA was $151M. Q3 net income was $18M and adjusted net income was $25M (+26% YoY). Cash, equivalents and investments totaled $793M with $200M undrawn credit facilities as of Sept. 30, 2025. The company raised full-year 2025 outlook to $806–809M revenue, gross margin ~72.5%, adjusted EBITDA $161–163M, and adjusted diluted EPS $2.10–2.12. METHODIQ brand formally launched in November 2025.
ODDITY (NASDAQ: ODD) launched METHODIQ on November 18, 2025, a telehealth platform delivering AI-driven, prescription and OTC dermatology care entirely online.
METHODIQ debuts with dermatology for acne, hyperpigmentation and eczema, a portfolio of 28 core products and >100 personalized treatment plans, backed by four years of development and large-scale consumer studies. The platform uses proprietary computer-vision models trained on >1 million clinical images for progress tracking and weekly clinician-adjusted care. ODDITY says METHODIQ aims to expand into other medical domains and leverage its ~60 million user base.
ODDITY (NASDAQ: ODD) will release its third quarter 2025 financial results after market close on November 19, 2025. A conference call is scheduled for November 20, 2025 at 8:30 a.m. ET. Investors can join by phone (US: 1-877-407-9208; international: 1-201-493-6784) and should reference ODDITY Third Quarter 2025 Earnings Call. A live webcast will be available at https://investors.oddity.com and an archive will remain on the site for seven days after the call. A phone replay will be accessible (US: 1-844-512-2921; international: 1-412-317-6671) using access code 13755969.
ODDITY Tech (NASDAQ: ODD) reported strong Q2 2025 results, with net revenue reaching $241 million, up 25% year-over-year. The company achieved $70 million in adjusted EBITDA and $49 million in net income.
Key financial metrics include a 72.3% gross margin, adjusted diluted EPS of $0.92, and a robust cash position of $815 million. The company raised its full-year 2025 outlook, projecting revenue between $799-804 million (23-24% growth) and adjusted EBITDA of $160-162 million.
Strategic developments include double-digit growth for IL MAKIAGE and SpoiledChild, international expansion, and progress on Brand 3 launch in Q4 2025. The company completed a $600 million exchangeable note offering with 0% coupon and maintains $200 million in undrawn credit facilities.
ODDITY Tech (NASDAQ: ODD) has scheduled its second quarter 2025 financial results announcement for August 4, 2025 after market close. The company will host a conference call to discuss the results on August 5, 2025, at 8:30 a.m. ET.
Investors can access the conference call by dialing 1-800-717-1738 (US) or 1-646-307-1865 (international). A webcast will be available on ODDITY's investor relations website, and a replay can be accessed using code 1106918.